Abiopharma

News list

Director Wang Jilei 🟢 acquired 39.3K shares (2 derivative) of ZTO Express (Cayman) Inc. (ZTO) Transaction Date: Mar 24, 2026 | Filing ID: 033544

Full text

News bot March 24, 2026, 10:22 a.m.
🔍 Wang Jilei (Director)

Company: ZTO Express (Cayman) Inc. (ZTO)

Report Date: 2026-03-24
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 39,324
Detailed Transactions and Holdings:
- Acquired 13,108 shares of American depositary shares (Direct)
  Date: 2026-03-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 28,646.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 13,108 shares of Restricted share units (Derivative)
  Date: 2026-03-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,108.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Acquired 13,108 shares of Restricted share units (Derivative)
  Date: 2026-03-23 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each represents one Class A ordinary share.
- F2: These restricted share units were granted on March 23, 2026 and vested in full on the same date.